Lantheus Holdings Inc

+0.58 (+3.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.28B
Current PEN/A
Forward PE 51.51
2yr Forward PE 21.66
See more stats
Estimates Current Quarter
Revenue$87.24 Million
Adjusted EPS-$0.01
See more estimates
10-Day MA$18.89
50-Day MA$17.04
200-Day MA$14.36
See more pivots

Lantheus Holdings, Inc. Stock, NASDAQ:LNTH

331 Treble Cove Road, North Billerica, Massachusetts 01862
United States of America
Phone: +1.978.671.8001
Number of Employees: 508


Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.